pH-sensitive peptide hydrogel encapsulating the anti-angiogenesis drug conbercept and chemotherapeutic drug dox as a combination therapy for retinoblastoma-Reference-Cited by-同舟云学术

pH-sensitive peptide hydrogel encapsulating the anti-angiogenesis drug conbercept and chemotherapeutic drug dox as a combination therapy for retinoblastoma

Published:2024 Issue:5 Volume:5 Page:2175-2184
ISSN:2633-5409
Container-title:Materials Advances
language:en
Short-container-title:Mater. Adv.

Author:

Fan Wen¹,Chen Mingkang¹,Raza Faisal²^ORCID,Zafar Hajra²,Jahan Faryal³,Chen Yuejian⁴,Ge Lexin¹,Yang Minyan⁵,Wu Yiqun⁶

Affiliation:

1. Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China

2. School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China

3. Shifa Tameer-e-Millat University Islamabad, Pakistan

4. Nanjing iChemBridge Pharmaceutical Technology Co., Ltd, China

5. The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, 225300, China

6. School of Pharmacy, China Pharmaceutical University, Nanjing, 211100, China

Abstract

Retinoblastoma (RB) is a malignant tumor originating from the retina.

Funder

Natural Science Foundation of Jiangsu Province

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/MA/D3MA01028G

Reference42 articles.

1. A Nanovaccine Based on Adjuvant Peptide FK‐13 and l‐Phenylalanine Poly(ester amide) Enhances CD8⁺ T Cell‐Mediated Antitumor Immunity

2. Redox responsive polymeric nanoparticles enhance the efficacy of cyclin dependent kinase 7 inhibitor for enhanced treatment of prostate cancer

3. Effects of polymer molecular weight on in vitro and in vivo performance of nanoparticle drug carriers for lymphoma therapy

4. General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor Study

5. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo